Literature DB >> 28975553

Selecting Rational Drug Combinations in Epilepsy.

Bassel Abou-Khalil1.   

Abstract

Monotherapy remains the standard initial therapy of epilepsy, but when the first antiepileptic drug (AED) fails, combination therapy may be considered. The choice of combination therapy should take into consideration pharmacokinetic interactions, as well as pharmacodynamic interactions related to mechanism of action. There is evidence that an AED combination with different mechanisms of action is more likely to be successful than a combination with the same mechanisms. The combination of lamotrigine and valproate has been demonstrated to be synergistic in its efficacy. However, there are limited data to support other synergistic AED combinations.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28975553     DOI: 10.1007/s40263-017-0471-7

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  81 in total

Review 1.  Antiepileptic drug interactions.

Authors:  J A French; B E Gidal
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

2.  Adjunctive lacosamide--5 years' clinical experience.

Authors:  Linda J Stephen; Kevin Kelly; Pamela Parker; Martin J Brodie
Journal:  Epilepsy Res       Date:  2014-07-06       Impact factor: 3.045

Review 3.  Mechanisms of action of antiepileptic drugs: the search for synergy.

Authors:  Carl E Stafstrom
Journal:  Curr Opin Neurol       Date:  2010-04       Impact factor: 5.710

4.  Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?

Authors:  F M Besag; D J Berry; F Pool; J E Newbery; B Subel
Journal:  Epilepsia       Date:  1998-02       Impact factor: 5.864

5.  The efficacy of carbamazepine combinations in epilepsy.

Authors:  J J Cereghino; J T Brock; J C Van Meter; J K Penry; L D Smith; B G White
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

6.  Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment.

Authors:  M W Lammers; Y A Hekster; A Keyser; H Meinardi; W O Renier; H van Lier
Journal:  Epilepsia       Date:  1995-05       Impact factor: 5.864

7.  Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.

Authors:  S Noachtar; E Andermann; P Meyvisch; F Andermann; W B Gough; J Schiemann-Delgado
Journal:  Neurology       Date:  2008-02-19       Impact factor: 9.910

8.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

9.  A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

Authors:  R H Mattson; J A Cramer; J F Collins
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

Review 10.  Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.

Authors:  S D Shorvon; E Trinka; B J Steinhoff; M Holtkamp; V Villanueva; J Peltola; E Ben-Menachem
Journal:  J Neurol       Date:  2017-01-18       Impact factor: 4.849

View more
  1 in total

1.  Response to antiseizure medications in epileptic patients with malformation of cortical development.

Authors:  Wei Chen; Bo Jin; Thandar Aung; Chenmin He; Cong Chen; Shan Wang; Yao Ding; Fang Ding; Chao Wang; Hong Li; Biao Jiang; Zhe Zheng; Haibin Dai; Junming Zhu; Yu Geng; Meiping Ding; Shuang Wang
Journal:  Ther Adv Neurol Disord       Date:  2021-10-12       Impact factor: 6.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.